HEPATITIS C sufferers in Scotland
are the first patients in the UK to be given access to a new treatment
that cures up to 99 per cent of cases in eight or 12 weeks.
The Scottish Medicines Consortium (SMC) has accepted for use
Harvoni for the treatment of chronic hepatitis C which affects one in
every 100 people in Scotland and causes more than 20 per cent of all
Approximately 50,000 people in Scotland are
infected with hepatitis C, which can cause liver cancer or liver failure
– equivalent to around 1 per cent of the Scottish population.
Labels: access to new drugs, Harvoni, Scotland